An immunotherapy combination continues to be effective in treating kidney cancer patients, and the FDA approves a therapy for a type of lung cancer.

by Kevin McLaughlin

9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

by Marci A. Landsmann

Researchers investigate how antibiotics might increase the risk of colon cancer, and the FDA approves a treatment for Waldenström macroglobulinemia.

by Bradley Jones

Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

by Bradley Jones

Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

by Marci A. Landsmann

Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

by Kevin McLaughlin

The father of a child diagnosed with brain cancer calls for better financial support for families, and a task force aims to find out more about AYA patients' quality of life.

by Bradley Jones

Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

by Marci A. Landsmann

Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

by Kevin McLaughlin

A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

by Bradley Jones